Events
BERGENBIO ASA: Invitation to THIRD quarter 2021 results
A webcast presentation by BerGenBio’s senior management team will take place Tuesday 16th November 2021…
Read More Nov 16, 2021 Online
BERGENBIO ASA: Invitation to PRESENTATION OF SECOND quarter and HALF YEAR 2021 results
August 17, 2021 A webcast presentation by BerGenBio’s senior management team will take place Tuesday…
Read More Aug 17, 2021 Online
BERGENBIO TO PRESENT AT ABGSC SEMINAR
Bergen, Norway, 21st May 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for…
Read More May 21, 2021 Online
BERGENBIO ASA: Invitation to FIRST quarter 2021 results
A webcast presentation by BerGenBio’s senior management team will take place Wednesday 19th May 2021…
Read More May 19, 2021 Online
BERGENBIO PRESENTING AT SACHS 7TH ANNUAL IMMUNO-ONCOLOGY INNOVATION FORUM
Bergen, Norway, 18 May 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for…
Read More May 18, 2021 Online
BERGENBIO ASA: Webcast presentation
A webcast presentation by BerGenBio's senior management team will take place Wednesday 18th May 2021…
Read More May 18, 2021 Online
